Researchers continue to excited about Retatrutide , a novel dual treatment showing significant results in early trials for body loss . It works by impacting several pathways : GLP-1 and GIP, which , when stimulated, assist influence hunger and boost metabolism . Preliminary reports demonstrate noteworthy body loss and possible benefits for patients